BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year ended December 31, 2014.
Blood Pressure Evaluation During Early Phase Trials
More attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated and not thoroughly defined during drug development.
ECHO Inter/Intra-Reader Variability
This report by Daniel B. Goodman, MD, and Polina Voloshko, MD, of BioTelemetry Research, formerly Cardiocore, describes the inter-reader and intra-reader variability in a central reference laboratory for 8 ECHO Cardiogram (ECHO) parameters.
Effect of Anagrelide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-Blind, Placebo- and Positive-Controlled, Thorough QT Study
Loxapine Delivered as a Thermally Generated Aerosol Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects
Association of Segmental Wall Motion Abnormalities Occurring During Hemodialysis with Post-Dialysis Fatigue
Major Cardiotoxicity Biomarkers During Oncology Development
Join in this free webinar with industry experts Sandra Chica, MD and Polina Voloshko, MD as they aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway. Register today to save your seat!
Evaluation of Atrial Fibrillation and Other Arrhythmias within Clinical Trials and Clinical Practice
Join this free webinar to learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTelemetry Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.
36th Annual Scientific Sessions
Boston Convention & Exhibition Center
Boston Convention and Exhibition Center
King of Prussia, PA
Walter E. Washington Convention Center